Immunological Density Shapes Recovery Trajectories in Long COVID
This research addresses the problem of understanding recovery drivers in Long COVID for patients and clinicians, but it is incremental as it builds on existing knowledge about vaccination effects.
The study analyzed longitudinal data from 13,511 Long COVID participants to identify recovery trajectories, finding that symptom severity slightly increased over time but decreased with cumulative vaccination, indicating recovery is primarily linked to repeated immunization.
Post-acute sequelae of SARS-CoV-2 infection (Long COVID) frequently persists for months, yet drivers of clinical remission remain incompletely defined. Here we analyzed 97,564 longitudinal PASC assessments from 13,511 participants with linked vaccination histories to disentangle passive temporal progression from vaccine-associated change. Using a clinically validated threshold (PASC $\geq 12$), trajectories separated into three phenotypes: Protected (persistently sub-threshold), Refractory (persistently symptomatic), and Responders (transitioning from symptomatic to recovered). Across the full cohort, symptom severity increased modestly with elapsed time ($r=0.0521$, $P=1.26\times10^{-59}$), whereas cumulative vaccination showed an inverse association with severity ($r=-0.0434$, $P=5.95\times10^{-42}$). In summary, baseline Long COVID severity appears clinically deterministic. In the absence of intervention, symptoms typically persist without spontaneous resolution. Recovery is primarily associated with repeated immunization.